Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Hematologic Malignancies

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1609851

This article is part of the Research TopicMitochondrial Dysregulation in Blood Cancers: Implications for Personalized Therapeutic StrategiesView all 3 articles

Deep Learning for Scene Understanding in Mitochondrial Dysregulation and Blood Cancer Diagnosis

Provisionally accepted
  • 1Southeast University, Nanjing, China
  • 2Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China

The final, formatted version of the article will be published soon.

Deep learning has emerged as a transformative tool in biomedical research, particularly in understanding disease mechanisms and enhancing diagnostic precision. Mitochondrial dysfunction has been increasingly recognized as a critical factor in hematological malignancies, necessitating advanced computational models to extract meaningful insights from complex biological and clinical data. Traditional diagnostic approaches rely heavily on histopathological examination and molecular profiling, yet they often suffer from subjectivity, limited scalability, and challenges in integrating multimodal data sources. To address these limitations, we propose a novel deep learning framework that integrates medical imaging, genomic information, and clinical parameters for comprehensive scene understanding in mitochondrial dysregulation-related blood cancers. Our methodology combines self-supervised learning, vision transformers, and graph neural networks to extract and fuse modality-specific features. The model architecture includes dedicated encoders for visual, genomic, and clinical data, which are integrated using an attention-based multimodal fusion mechanism. Adversarial domain adaptation and uncertainty quantification modules are incorporated to enhance generalizability and decision reliability. Our model employs a multimodal fusion strategy with attention-based learning mechanisms to enhance predictive accuracy and interpretability. Adversarial domain adaptation ensures robustness across heterogeneous datasets, while uncertainty quantification techniques provide reliable decision support for personalized treatment strategies. Experimental results demonstrate significant improvements in classification performance, with our approach outperforming conventional machine learning and rule-based diagnostic systems. By leveraging deep learning for enhanced scene understanding, this work contributes to a more precise and scalable framework for the early detection and management of blood cancers.

Keywords: deep learning, mitochondrial dysregulation, Blood Cancer Diagnosis, multimodal fusion, predictive analytics

Received: 11 Apr 2025; Accepted: 01 Sep 2025.

Copyright: © 2025 Chang, Qin and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jianming Chang, Southeast University, Nanjing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.